A
Power Law company profile
Araris Biotech
Biotech & Life Sciences · Wädenswil, Switzerland · Founded 2019 Unicorn
Global footprint
Where Araris Biotech has talent and traffic
Web traffic by country
4.5K
monthly visits
across markets
across markets
🇺🇸 United States53.3%
🇯🇵 Japan31.1%
🇨🇭 Switzerland15.6%
🇮🇳 India2.2%
Patent intelligence
$1M patent portfolio · 8 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$1M
0.09% of valuation · 1907.1× smaller than top peer Ablynx ($2B)
8 active patent families
Where Araris Biotech innovates
Molecular biologyAntiendomysial antibodiesPharmaceutical drugCamptothecinDisease
Above peer median on Strategic · Below peer median on Market
Quality vs same-sector peers
Araris Biotech on the five Patsnap quality dimensions
Araris Biotech in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Araris Biotech concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Araris Biotech and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Araris Biotech on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.